GL1X · GenesisL1 explorer

Research workbench

Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified by fragment screening and structure based drug design

Analyse Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZT0
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.95
Source
HUMAN IMMUNODEFICIENCY VIRUS
Molecule
Integrase
EC
2.7.7.-
UniProt
Q76353
Ligands
ZT0, SO4
Pockets
7 · best druggability 0.64

Structure

x-ray diffraction · resolution 1.95 · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIntegrase (EC 2.7.7.-)protein14953% helix, 21% strandQ76353

Ligands and binding sites

  • ZT0 · (4-carboxy-1,3-benzodioxol-5-yl)-N-{2-[(4-methoxybenzyl)carbamoyl]benzyl}-N-methylmethanaminium · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12410.640.8228empty
21900.480.7636empty
31250.470.7818ZT0
41180.470.7926empty
51110.460.7925empty

Interfaces

1 interface between chains.

  • A–B · 1477 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 3ZT0 · Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.